Page last updated: 2024-11-07

sodium percarbonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium percarbonate: RN given refers to unspecified Na salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID181880
MeSH IDM0106855
PubMed CID159762
MeSH IDM0106855

Synonyms (52)

Synonym
carbonoperoxoic acid
67283-79-8
peroxycarbonic acid
563-69-9
percarbonic acid
FT-0627162
dihydroxycarboxylic acid
MMCOUVMKNAHQOY-UHFFFAOYSA-N
carbonic acid oxide
DTXSID70864313
perdox
einecs 239-707-6
disodium carbonate, hydrogen peroxide (2:3)
disodium carbonate, compound with hydrogen peroxide (2:3)
oxyper
sodium percarbonate
sodium carbonate peroxide
fb sodium percarbonate
peroxy sodium carbonate
sodium percarbonate, avail. h2o2 20-30 %
15630-89-4
disodium carbonate hydrogen peroxide (2:3)
z7g82nv92p ,
unii-z7g82nv92p
hsdb 8161
ec 239-707-6
sodium carbonate peroxyhydrate
FT-0688134
sodium percarbonate [mart.]
sodium carbonate peroxide [inci]
peroxodicarbonate disodium
sodium percarbonate [who-dd]
peroxodicarbonate disodium [who-dd]
MSLRPWGRFCKNIZ-UHFFFAOYSA-J
DTXSID3029736
sodium percarbonate, cp
Q420070
tetrasodium;hydrogen peroxide;dicarbonate
hydrogen peroxide, compound with disodium carbonate (3:2)
aspen foot patrol
sodium carbonate sesquiperoxide (2na2co3.3h2o2)
disodium carbonate sesquiperoxide
carbonic acid disodium salt, compound with hydrogen peroxide (2:3)
disodium carbonate compound with hydrogen peroxide (na2co3.1.5 h2o2)
sodium percarbonate (mart.)
disodium carbonate compound with hydrogen peroxide (2:3)
ecox-c
sodium percarbonate (na2co3.1.5h2o2)
hydrogen peroxide (h2o2), compound with disodium carbonate (3:2)
usepa/opp pesticide code: 128860
hoof care
sodium percarbonates

Research Excerpts

Overview

Sodium percarbonate (SP) is a relatively low-cost and stable solid oxidizer with a small environmental burden. It is a common reagent used for in situ remediation of contaminated soil.

ExcerptReferenceRelevance
"Sodium percarbonate is a readily available and environmentally benign oxidant that is studied in these reactions for the first time."( Asymmetric Epoxidation of Olefins with Sodium Percarbonate Catalyzed by
Bryliakov, KP; Drozd, VA; Ottenbacher, RV, 2022
)
1.71
"Sodium percarbonate (SP) is a relatively low-cost and stable solid oxidizer with a small environmental burden. "( 2-[Bis(carboxymethyl)amino] propanoic acid-Chelated Copper Chelate Enhances Bacterial Elimination by Sodium Percarbonate.
Ishizaki, U; Sato, K; Takahashi, I; Yoshimune, K, 2021
)
2.28
"Sodium percarbonate (SPC) is a common reagent used for in situ remediation of contaminated soil. "( Response of environmental variables and microbial community to sodium percarbonate addition to contaminated sediment.
Pan, H; Sun, G; Xu, M; Yang, X; Zhong, Y, 2018
)
2.16

Dosage Studied

ExcerptRelevanceReference
"The control of biofilm and effluent contamination of dental unit water lines (DUWL) includes additions of antimicrobial solutions, as well as automatic dosing units."( Effect of a dental unit waterline treatment solution on composite-dentin shear bond strengths.
DePaola, LG; Kelley, JI; Meiller, TF; von Fraunhofer, JA, 2004
)
0.32
" Briefly, APIs/ dosage forms were allowed to be in close contact with deactivation agents for a specified period of time and percentage decrease in the amount of API from the initial amount was measured."( Development of Disposal Systems for Deactivation of Unused/Residual/Expired Medications.
Anderson, C; Banga, AK; Fowler, W; Herwadkar, A; Korey, A; Singh, N, 2016
)
0.43
" Adsorption agents resulted in more universal deactivation with activated carbon resulting in efficient deactivation of most APIs and all dosage forms tested."( Development of Disposal Systems for Deactivation of Unused/Residual/Expired Medications.
Anderson, C; Banga, AK; Fowler, W; Herwadkar, A; Korey, A; Singh, N, 2016
)
0.43
" However, coagulation alone exhibited relatively weak removal effect for algal pollutants, and the coagulant residues due to the excess dosage also raised concerns."( Coupling sodium percarbonate (SPC) oxidation and coagulation for membrane fouling mitigation in algae-laden water treatment.
Cheng, X; Hou, C; Jin, Y; Lian, J; Liang, H; Luo, C; Ren, Z; Wu, D; Zhang, L; Zhu, X, 2021
)
1.04
" Also, 1 mM HPO dosage led to 100% antibiotic removal ratios after 10 min of DBD treatment and a TOC removal of 62."( Non-thermal plasma activated peroxide and percarbonate for tetracycline and oxytetracycline degradation: Synergistic performance, degradation pathways, and toxicity evaluation.
Kyere-Yeboah, K; Qiao, XC, 2023
)
0.91
" Results show that percarbonate largely reduces the required ferrate dosage for fermentation improvement, and their combination exhibits obvious synergistic effects on SCFAs accumulation and sludge reduction."( Percarbonate-strengthened ferrate pretreatment for enhancing short-chain fatty acids production from sewage sludge.
Guo, H; Liu, Y; Ni, BJ; Wang, X; Wang, Y; Zhang, Z; Zhu, T, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (107)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (2.80)18.7374
1990's3 (2.80)18.2507
2000's23 (21.50)29.6817
2010's38 (35.51)24.3611
2020's40 (37.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.70 (24.57)
Research Supply Index4.63 (2.92)
Research Growth Index5.25 (4.65)
Search Engine Demand Index176.17 (26.88)
Search Engine Supply Index3.95 (0.95)

This Compound (55.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials10 (10.87%)5.53%
Reviews3 (14.29%)6.00%
Reviews3 (3.26%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other18 (85.71%)84.16%
Other79 (85.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]